fundvisualizer.com

JNL/Newton Equity Income IF00000Z1WK

Performance (before sales charge)

As of 01/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2023
Stock
92.39%
Non-U.S. Stock
4.82%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
2.78%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Top 10 holdings

As of 12/31/2023

JPMorgan Chase & Co
4.41%
Medtronic PLC
3.57%
Berkshire Hathaway Inc Class B
3.43%
Danaher Corp
3.02%
CRH PLC
2.79%
Govt Money Mkt Fd Instl Cl
2.77%
AbbVie Inc
2.67%
Becton Dickinson & Co
2.62%
AT&T Inc
2.47%
International Game Technology PLC
2.41%
Fund assets

$1.92 Billion

Share class

Inst

Morningstar category

Large Value

Expense ratio

0.61%

Investment objective

Growth and Income

Documents